http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. Millions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests. http://www.physorg.com/news180040030.html Medicine & Health Mon, 14 Dec 2009 21:10:03 EST news180040030 Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study. http://www.physorg.com/news177597196.html Medicine & Health Mon, 16 Nov 2009 13:30:01 EST news177597196 The world's largest quality of life study of chronic angina patients has revealed that almost one in three experience frequent chest pain, which affects their daily life. http://www.physorg.com/news172225014.html Medicine & Health Tue, 15 Sep 2009 09:17:24 EST news172225014 A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS. The study, published in the August 26, 2009 issue of the Journal of the American Medical Association (JAMA), found however that overall there was no significant difference in mortality observed between the sexes after a heart attack. The large observational study pooled 136,247 ACS patients from 11 independent, international randomized clinical trials between 1993 and 2006. http://www.physorg.com/news170437772.html Medicine & Health Tue, 25 Aug 2009 17:00:02 EST news170437772 (PhysOrg.com) -- Men with angina are twice as likely to have a heart attack and almost three times as likely to suffer a heart disease-related death than women with the same condition, finds a study published on bmj.com today (August 7). http://www.physorg.com/news168867652.html Medicine & Health Fri, 07 Aug 2009 13:00:01 EST news168867652 Twenty percent of American deaths each year are caused by heart attack or angina, sometimes without any warning. http://www.physorg.com/news160059502.html Biology Mon, 27 Apr 2009 13:58:47 EST news160059502 Healthcare Reform should start with "evidence-based reimbursement", structuring physician payment incentives around existing empirical evidence of clinical benefit, which would improve quality and reduce the cost of healthcare, says a commentary written by two cardiologists and published in Circulation: Cardiovascular Quality and Outcomes. http://www.physorg.com/news159465899.html Medicine & Health Mon, 20 Apr 2009 17:05:34 EST news159465899 Routine screening for coronary artery disease in type 2 diabetes patients with no symptoms of angina or a history of coronary disease is unnecessary and may lead initially to more invasive and costly heart procedures, according to researchers at Yale School of Medicine. They report their findings in the April 15 Journal of the American Medical Association. http://www.physorg.com/news158927121.html Medicine & Health Tue, 14 Apr 2009 11:27:40 EST news158927121 Most chest pain is caused by fatty deposits that hinder blood flow through the main, spaghetti-thick arteries of the heart. http://www.physorg.com/news157385811.html Medicine & Health Fri, 27 Mar 2009 15:17:28 EST news157385811 A compound designed to prevent chest pains in heart patients has shown promising results in animal studies, say scientists. In the second issue of the British Journal of Pharmacology to be published by Wiley-Blackwell, researchers from the Centre de Recherche Pierre Fabre in France, show that the novel compound F15845 has anti-angina activity and can protect heart cells from damage without the unwanted side effects often experienced with other drugs. http://www.physorg.com/news150536526.html Medicine & Health Wed, 07 Jan 2009 07:42:06 EST news150536526 Results from a late-breaking clinical trial, presented at the 2008 Canadian Cardiology Congress (CCC) in Toronto, show for the first time that combining the pure heart rate reduction medication ivabradine to current treatments of patients with stable angina improves their exercise capacity. http://www.physorg.com/news144581157.html Medicine & Health Thu, 30 Oct 2008 10:25:57 EST news144581157